Kinetics, Biodistribution, Dosimetry and Safety Phase 1 Study With 68Ga-PSMA-11 Sterile Cold Kit, in Healthy Male Volunteers and Patients With Limited Recurrent Prostate Cancer
Not yet recruiting
Phase of Trial: Phase I
Latest Information Update: 04 Dec 2017
At a glance
- Drugs Gallium 68 PSMA (Primary)
- Indications Prostate cancer
- Focus Pharmacokinetics
- 29 Nov 2017 Planned End Date changed from 31 Jul 2018 to 30 Nov 2018.
- 29 Nov 2017 Status changed from withdrawn prior to enrolment to not yet recruiting.
- 10 Aug 2017 Status changed from not yet recruiting to withdrawn prior to enrolment as the ethics committee did not approved the start of the study